145 related articles for article (PubMed ID: 37845784)
1. Bilirubin Elevation Caused by Naproxen Overdose: A Case Report Highlighting Laboratory Interference.
Heutlinger O; Mathew T; Fujimoto D; Bharani V; Yamarik R; Baz S
Am J Case Rep; 2023 Oct; 24():e941267. PubMed ID: 37845784
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing naproxen metabolite interference in total bilirubin assays.
Saifee NH; Ranjitkar P; Greene DN
Clin Biochem; 2016 Apr; 49(6):514-517. PubMed ID: 26589001
[TBL] [Abstract][Full Text] [Related]
3. Spurious hyperbilirubinemia caused by naproxen.
Al Riyami N; Zimmerman AC; Rosenberg FM; Holmes DT
Clin Biochem; 2009 Jan; 42(1-2):129-31. PubMed ID: 18977340
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.
Eccleston C; Cooper TE; Fisher E; Anderson B; Wilkinson NM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012537. PubMed ID: 28770976
[TBL] [Abstract][Full Text] [Related]
5. Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis.
Delaney JA; Biggs ML; Kronmal RA; Psaty BM
Pharmacoepidemiol Drug Saf; 2011 Jan; 20(1):83-9. PubMed ID: 21182156
[TBL] [Abstract][Full Text] [Related]
6. Naproxen metabolites interfere with certain bilirubin assays: elimination of interference by using a Roche bilirubin assay on the Hitachi 917 analyzer.
Dasgupta A; Langman LJ; Johnson M; Chow L
Am J Clin Pathol; 2010 Jun; 133(6):878-83. PubMed ID: 20472845
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.
Katz JN; Smith SR; Collins JE; Solomon DH; Jordan JM; Hunter DJ; Suter LG; Yelin E; Paltiel AD; Losina E
Osteoarthritis Cartilage; 2016 Mar; 24(3):409-18. PubMed ID: 26525846
[TBL] [Abstract][Full Text] [Related]
8. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
[TBL] [Abstract][Full Text] [Related]
9. Naproxen with or without an antiemetic for acute migraine headaches in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009455. PubMed ID: 24142263
[TBL] [Abstract][Full Text] [Related]
10. A look at the safety profile of over-the-counter naproxen sodium: a meta-analysis.
Bansal V; Dex T; Proskin H; Garreffa S
J Clin Pharmacol; 2001 Feb; 41(2):127-38. PubMed ID: 11210392
[TBL] [Abstract][Full Text] [Related]
11. Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships.
Smolinske SC; Hall AH; Vandenberg SA; Spoerke DG; McBride PV
Drug Saf; 1990; 5(4):252-74. PubMed ID: 2198051
[TBL] [Abstract][Full Text] [Related]
12. Massive naproxen overdose with serial serum levels.
Al-Abri SA; Anderson IB; Pedram F; Colby JM; Olson KR
J Med Toxicol; 2015 Mar; 11(1):102-5. PubMed ID: 24756481
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
Biskupiak JE; Brixner DI; Howard K; Oderda GM
J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
[TBL] [Abstract][Full Text] [Related]
14. Severe poisoning with naproxen causing coagulopathy.
Lelièvre B; Drouillard I; Thill C; Le Roux G; Bruneau C; Mahé J; Deguigne M; Boels D
Basic Clin Pharmacol Toxicol; 2020 May; 126(5):458-463. PubMed ID: 31742906
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics.
Moore N; Scheiman JM
Postgrad Med; 2018 Mar; 130(2):188-199. PubMed ID: 29417856
[TBL] [Abstract][Full Text] [Related]
16. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
[TBL] [Abstract][Full Text] [Related]
17. Safety profile of over-the-counter naproxen sodium.
DeArmond B; Francisco CA; Lin JS; Huang FY; Halladay S; Bartziek RD; Skare KL
Clin Ther; 1995; 17(4):587-601; discussion 586. PubMed ID: 8565023
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies.
Milsom I; Minic M; Dawood MY; Akin MD; Spann J; Niland NF; Squire RA
Clin Ther; 2002 Sep; 24(9):1384-400. PubMed ID: 12380631
[TBL] [Abstract][Full Text] [Related]
19. Low Serum Naproxen Concentrations Are Associated with Minimal Pain Relief: A Preliminary Study in Women with Dysmenorrhea.
Oladosu FA; Tu FF; Garrison EF; Dillane KE; Roth GE; Hellman KM
Pain Med; 2020 Nov; 21(11):3102-3108. PubMed ID: 32488234
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug interactions involving common prescription and over-the-counter analgesic agents.
Hersh EV; Pinto A; Moore PA
Clin Ther; 2007; 29 Suppl():2477-97. PubMed ID: 18164916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
